Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The proximal origin of SARS-CoV-2

(2020) Kristian G. Andersen et al.   NATURE MEDICINE

Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic

(2020) Wallace Brownlee et al.   NEUROLOGY

B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran

(2020) Farinaz Safavi et al.   Multiple Sclerosis and Related Disorders

COVID-19 in persons with multiple sclerosis treated with ocrelizumab – A pharmacovigilance case series

(2020) Richard Hughes et al.   Multiple Sclerosis and Related Disorders

COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?

(2020) Giovanni Novi et al.   Multiple Sclerosis and Related Disorders

Cytokine-producing B lymphocytes—key regulators of immunity

(2008) Frances E Lund   CURRENT OPINION IN IMMUNOLOGY